Login / Signup

Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients.

Jorn S HeerinkEugenie GemenRuud OudegaGeert-Jan GeersingRogier HopstakenRon Kusters
Published in: The journal of applied laboratory medicine (2021)
Netherlands Trial Register NL5974. (METC protocol number: 16-356/M; NL56475.041.16.).
Keyphrases
  • venous thromboembolism
  • primary care
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • open label